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Syllabus – Psyx 532 – Autumn 2014 
Advanced Psychopathology 
 
Meeting Location and Time 
CPC 121 
Monday, Wednesday 12:10 – 1:30 pm 
 
Instructor Information 
Instructor:  Bryan Cochran, Ph.D. 
Office:  Skaggs Bldg. 145 
Email:  bryan.cochran@umontana.edu  
Phone:  406.243.2391 
Office hours:  Monday 2:30 – 4:00, Wednesday 9:00 – 10:30, or by appointment 
 
Course Guidelines and Policies 
Disability Modifications 
The University of Montana assures equal access to instruction through collaboration between students 
with disabilities, instructors, and Disability Services for Students.  If you think you may have a disability 
adversely affecting your academic performance, and you have not already registered with Disability 
Services, please contact Disability Services in Lommasson Center 154 or call 406.243.2243.  I will work 
with you and Disability Services to provide an appropriate modification. 
Academic Misconduct 
All students must practice academic honesty.  Academic misconduct is subject to an academic penalty 
by the course instructor and/or a disciplinary sanction by the University.  All students need to be familiar 
with the Student Conduct Code. 
Incompletes 
Departmental and university policies regarding incompletes do not allow changing “incomplete” grades 
after one year has passed since the “I” was granted. 
Pass/No Pass 
For students taking this course P/NP, a P is a grade of A, B, or C.  A NP is a grade of D or F. 
Exiting Gracefully 
Instructor permission is required to drop this course once the 15th day of instruction has passed. 
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Course Description 
Psyx 532 is a graduate-level overview of adult psychopathology, encompassing etiological theories, 
epidemiology, and treatment approaches used with all major behavioral disorders. 
Learning Outcomes 
1. Students will learn about the development of the current diagnostic system, the DSM-5, and the 
issues that were involved in the recent revision of the manual. 
2. Students will learn how to evaluate a client’s reported symptoms and how to assign DSM 
diagnoses. 
3. Students will become familiar with both basic psychopathology and treatment outcome 
research. 
4. Students will write extensively about key issues in psychopathology and will receive feedback on 
both writing content and style. 
5. Students will learn about psychopathology from multiple sources:  diagnostic manuals, research 
articles, and case studies. 
6. Students will learn how to integrate diagnostic data with theory in the process of case 
formulation. 
Grading/Evaluation 
It is assumed that the best measure of your having met the objectives of this course is your ability to 
synthesize the material you have learned and to present your ideas to others (orally and in writing).  
With this in mind, evaluation of your progress will be through the following components: 
 
45% Responses to Readings—Every two weeks, you will be asked to turn in a written response to one or 
more of your assigned readings.  These are due by the beginning of class on Mondays (dates with an 
asterisk under ‘course organization’ are turn-in days for responses; seven total are required; on weeks in 
which Monday is a holiday, responses are due on Wednesday).  Each response should directly address 
your reactions to assigned material over the past two weeks.  An excellent response integrates ideas 
presented from multiple readings, theoretical perspectives learned in- or outside of this class, and your 
personal reactions to the material in equal measure.  A good response is an in-depth reaction to one or 
two specific ideas presented in the readings.  A poor response is an article summary or paraphrasing of 
the assigned material. 
 
There is no page length requirement for your responses; however, anything two pages or less would 
need to be extremely concise and well organized to comprise an excellent response.  I will not grade 
your first response due on 9/4 but will provide you with feedback that will assist in writing future 
responses.  The remaining 6 responses will be assigned 0-7 points, totaling a possible 42 points of your 
final course grade (you will receive three points for handing in your response on 9/4). 
 
15% DSM Quizzes—during the semester, there will be 3 announced quizzes to assess your 
comprehension and knowledge of the DSM.  The format will be short-answer.  Quiz dates will be 
scheduled in class. 
 
25% Final Paper—the goal of this paper is to present a thorough review of one of the major topics in the 
field of psychopathology (e.g., exciting research areas, current controversies).  As a general guideline, 
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construct a paper similar in length and in depth of understanding to a Psychological Bulletin article.  
Final papers should be at least 20 pages excluding title page, references, etc..  Your paper should have 
an abstract and should adhere to APA format.  Individual meetings with me by 10/25 to establish your 
topic are required; provide at or before this meeting an approximately 2 page overview of your planned 
topic. 
 
 Examples of good paper topics are: 
• Changes in the meaning of substance use disorder diagnoses with the abandonment of the 
abuse/dependence distinction in DSM-5 
• Defining the concept of psychological disorder: Is there a possible synthesis between medical 
model and “harmful dysfunction” approaches?  
• Somatoform disorders and the implication of a mind-body connection in current diagnostic 
practice 
• Epidemiology of mental disorders from a cross-cultural perspective: What barriers hinder 
comparisons between cultures? 
 
5% Presentation of Final Paper—in the final week of class, you will make a 20 minute presentation on 
the topic area of your paper. 
 
10% Course Participation—your understanding of the material in class will be demonstrated through 
well-constructed questions and contributions to discussion.  Of course, attendance is part of 
participation. 
 
Final grades will be calculated using the plus/minus system (e.g., an overall grade of 90-92% is an A-, 77-
79 is a C+, etc.). 
 
Ungraded exercises will consist of informal case “consultations” in which you will receive a clinical case 
description and you will develop (in collaboration with your colleagues during class) diagnostic 
hypotheses and a case formulation. 
 
Required Texts 
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 
5th ed. Washington, DC: American Psychiatric Publishing. 
 
Halgin, R. P., & Whitbourne, S. K. (1998). A casebook in abnormal psychology: From the files of experts. 
NY: Oxford. 
 
Readings from relevant journals or other books are available on the Moodle site for this course. These 
materials comprise the bulk of your reading assignments over the course of the semester. 
 
Course Schedule 
Dates Topics 
Week 1 (8/25) Introduction to Psychopathology, Case Formulation, and the DSM 
Week 2 (9/3; response due *) 
Week 3 (9/8) 
The Construct of “Disorder,” Stigma, and the Hot-Off-the-Presses DSM-
5! 
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Dates Topics 
Week 4 (9/15*) Epidemiology and Comorbidity 
Week 5 (9/22) Mood Disorders: Unipolar 
Week 6 (9/29*) Mood Disorders: Bipolar 
Week 7 (10/6) Anxiety Disorders: Panic, Agoraphobia, Specific Phobias, Generalized Anxiety Disorder, and Social Anxiety Disorder 
Week 8 (10/13*) Schizophrenia Spectrum Disorders 
Week 9 (10/20) Substance-Related and Addictive Disorders: Etiology and Epidemiology 
Week 10 (10/27*) Substance-Related and Addictive Disorders: Current Research and Treatment 
Week 11 (11/3) Eating Disorders and Dissociative Disorders 
Week 12 (11/10*) Personality Disorders 
Week 13 (11/17) Personality Disorders (cont.) 
Week 14 (11/24*) Somatic Symptom and Related Disorders, Sexual Disorders, Impulse Control Disorders, Neurocognitive Disorders  
Weeks 15 and 16 (12/1, 12/8) 
Final Thoughts: Synthesis and Presentations 
The final exam is scheduled for this class on 12/10 from 10:10-12.  The 
final paper is due at this time. 
Readings 
Note:  
Subscripts following a citation indicate the intended day of the week that we will discuss each article or 
chapter in class (M=Monday, W=Wednesday). For weeks 2, 12, and 14, there is only one meeting day for 
the class and subscripts are not used. DSM readings apply to the entire week and should be read for 
Mondays.  
Week 1:  
Introduction to Psychopathology, Case Formulation, and the DSM 
 DSM-5– Introduction, pp. 5-17; Use of the Manual, pp. 19-24.  
 Halgin text—Chapter 1, The Therapeutic Process, pp. 1-6 W 
 
Hays, P. A. (2008). Making sense and moving on: Culturally responsive diagnosis and the DSM-IV-TR. In 
P. A. Hays (Ed.), Addressing cultural complexities in practice: Assessment, diagnosis, and therapy, 2nd ed. 
(pp. 153-172). Washington, DC: APA. W 
 
Persons, J., Davidson, J., & Tompkins, M. (2000). Individualized case formulation and treatment 
planning. In J. Persons, J. Davidson, et al. (Eds.), Essential components of cognitive-behavior therapy for 
depression (pp. 25-51). Washington, DC: APA. W 
 
Segal, D. L., & Coolidge, F. L. (2001). Diagnosis and classification. In M. Hersen & V. B. Van Hasselt (Eds.), 
Advanced abnormal psychology, second edition (pp. 5-22). New York: Kluwer/Plenum. M, W 
Week 2:   
The Construct of “Disorder,” Stigma, and the Hot-Off-the-Presses DSM-V! 
Read the highlights of changes to DSM-5 
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Adam, D. (2013). On the spectrum. Nature, 496, 416-428. 
 
Flanagan, E. H., Keeley, J., & Blashfield, R. K. (2008). An alternative hierarchical organization of the 
mental disorders of the DSM-IV. Journal of Abnormal Psychology, 117, 693-698. 
 
Frances, A. J., & Widiger, T. (2012). Psychiatric diagnosis: Lessons from the DSM-IV past and cautions for 
the DSM-5 future. Annual Review of Clinical Psychology, 8, 109-130.  
 
Hyman, S. E. (2010). The diagnosis of mental disorders: The problem of reification. Annual Review of 
Clinical Psychology, 6, 155-179. 
 
Sirey, J. A., Bruce, M. L., Alexopoulos, G. S., et al. (2001). Perceived stigma as a predictor of treatment 
discontinuation in young and older outpatients with depression. American Journal of Psychiatry, 158, 
479-481. 
Week 3:   
Epidemiology and Comorbidity 
Kessler, R. C., Berglund, P. A., Bruce, M. L., et al. (2001). The prevalence and correlates of untreated 
serious mental illness. Health Services Research, 36, 987-1007. W 
 
Miller, G. A., & Rockstroh, B. (2013). Endophenotypes in psychopathology research: Where do we stand? 
Annual Review of Clinical Psychology, 9, 177-213. W 
 
Kessler, R. C., Demler, O., Frank, R. G., et al. (2005). Prevalence and treatment of mental disorders, 1990 
to 2003. New England Journal of Medicine, 352, 2515-2523. M 
 
Kilpatrick, D. G., Ruggiero, K. J., Acierno, R., et al. (2003). Violence and risk of PTSD, major depression, 
substance abuse/dependence, and comorbidity: Results from the national survey of adolescents. Journal 
of Consulting and Clinical Psychology, 71, 692-700. W 
 
Narrow, W. E., Rae, D. S., Robins, L. N., & Regier, D. A. (2002). Revised prevalence estimates of mental 
disorders in the United States. Archives of General Psychiatry, 59, 115-123. M 
 
Vander Stoep, A., & Link, B. (1998). Social class, ethnicity, and mental illness: The importance of being 
more than earnest. American Journal of Public Health, 88, 1396-1402. M 
Week 4:   
Mood Disorders: Unipolar 
 DSM-5 – pp. 155-188 
 
Chapter 11, Halgin Text (Flora) M 
 
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., et al. (2006). 
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute 
treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658-670. W 
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Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002). Treatment and prevention of depression. 
Psychological Science in the Public Interest, 3, 39-77. W 
 
Nolen-Hoeksema, S. (2012). Emotion regulation and psychopathology: The role of gender. Annual 
Review of Clinical Psychology, 8, 161-187. M 
 
Ryder, A. G., Yang, J., Zhu, X., et al. (2008). The cultural shaping of depression: Somatic symptoms in 
China, psychological symptoms in North America? Journal of Abnormal Psychology, 117, 300-313. M 
Week 5:   
Mood Disorders: Bipolar 
 DSM-5 – pp. 123-154  
 
Chapter 10, Halgin Text (Irene) W 
 
Alloy, L. B., & Abramson, L. Y. (2010). The role of the behavioral approach system (BAS) in bipolar 
spectrum disorders. Current Directions in Psychological Science, 19, 189-194. w 
 
Mansell, W., & Pedley, R. (2008). The ascent into mania: A review of psychological processes associated 
with the development of manic symptoms. Clinical Psychology Review, 28, 494-520. M 
 
Phillips, M. L., & Kupfer, D. J. (2013). Bipolar disorder diagnosis: Challenges and Future Directions. The 
Lancet, 381, 1663-1671. M 
 
Severus, E., Schaaff, N., & Möller, H. (2012). State of the art: Treatment of bipolar disorders. CNS 
Neurosciences & Therapeutics, 18, 214-218. W 
 
Tyrer, S. (2006). What does history teach us about factors associated with relapse in bipolar affective 
disorder? Journal of Psychopharmacology, 20(Suppl. 2), 4-11. W 
Week 6:   
Anxiety Disorders: Panic, Agoraphobia, Specific Phobias, Generalized Anxiety Disorder, & Social 
Anxiety Disorder 
 DSM-5 – pp. 189-233 
 
 Chapter 4, Halgin Text (Eric) M 
 
Barlow, D. H. (2002). The experience of anxiety: Shadow of intelligence or specter of death? In Anxiety 
and its Disorders: The Nature and Treatment of Anxiety and Panic, 2nd. Ed. (pp. 1-36). New York: Guilford. 
M 
 
Hope, D. A., Heimberg, R. G., Juster, H. R., & Turk, C. L. (2000). Managing Social Anxiety: A Cognitive-
Behavioral Therapy Approach (pp. 29-42). The Psychological Corporation. W 
 
Morrison, A. S., & Heimberg, R. G. (2013). Social anxiety and social anxiety disorder. Annual Review of 
Clinical Psychology, 9, 249-274. W 
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Ruscio, A. M., Chiu, W. T., Roy-Byrne, P., Stang, P. E., Stein, D. J., Wittchen, H, et al. (2007). Broadening 
the definition of generalized anxiety disorder: Effects on prevalence and associations with other 
disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders, 21, 662-676. M 
Week 7:   
Anxiety Disorders: Obsessive-Compulsive and Related Disorders, Trauma & Stressor-Related Disorders 
 DSM-5– pp. 235-290 
 
 Halgin Text: Chapter 5 (Judy) M and Chapter 6 (Sheila and Karen) W 
 
Abramowitz, J. S., Franklin, M. E., & Cahill, S. P. (2003). Approaches to common obstacles in the 
exposure-based treatment of obsessive-compulsive disorder. Cognitive and Behavioral Practice, 10, 14-
22. M 
 
Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for posttraumatic 
stress disorder in trauma-exposed adults. Journal of Consulting and Clinical Psychology, 68, 748-766. W 
 
Foa, E. B., Dancu, C. V., Hembree, E. A., Jaycox, L. H., Meadows, E. A., & Street, G. P. (1999). A 
comparison of exposure therapy, stress inoculation training, and their combination for reducing 
posttraumatic stress disorder in female assault victims. Journal of Consulting and Clinical Psychology, 67, 
194-200. W 
 
Rodrigues, C. S., & Renshaw, K. D. (2010). Associations of coping processes with posttraumatic stress 
disorder symptoms in national guard/reserve service members deployed during the OEF-OIF era. Journal 
of Anxiety Disorders, 24, 694-699. W 
 
Sanders, J., Whitty, P., Murray, D., & Devitt, P. (2006). Delusions or obsessions: The same only different?  
Psychopathology, 39, 45-48. M 
Week 8:   
Schizophrenia Spectrum Disorders 
 DSM-5– pp. 87-122 
 
 Chapter 13, Halgin text (Jeff) M 
 
Aleman, A, & Larøi, F. (2008). The phenomenology of hallucinations. In A. Aleman & F. Larøi (Eds.), 
Hallucinations: The science of idiosyncratic perception (pp. 25-32). Washington, DC: APA. M 
 
Mueser, K. T., Deavers, F., Penn, D. L., & Cassisi, J. E. (2013). Psychosocial treatments for schizophrenia. 
Annual Review of Clinical Psychology, 9, 465-497. W 
 
Salyers, M. P., & Mueser, K. T. (2001). Schizophrenia. In Hersen & Van Hasselt (Eds)., Advanced 
Abnormal Psychology, Second Edition. New York: Kluwer.  pp.325-353. M 
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Weisman, A., Rosales, G., Kymalainen, J., & Armesto, J. (2005). Ethnicity, family cohesion, religiosity and 
general emotional distress in patients with schizophrenia and their relatives. Journal of Nervous and 
Mental Disease, 193, 359-368. W 
Week 9:   
Substance-Related and Addictive Disorders: Etiology and Epidemiology 
 DSM-5– pp. 481-589 
 
 Chapter 16, Halgin Text (John) M 
 
Brook, D. W., Brook, J. S., Zhang, C., Cohen, P., & Whiteman, M. (2002). Drug use and the risk of major 
depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry, 
59, 1039-1044. W 
 
Martin, C. S., Chung, T., & Langenbucher, J. W. (2008). How should we revise diagnostic criteria for 
substance use disorders in the DSM-V? Journal of Abnormal Psychology, 117, 561-575. M 
 
McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical 
illness. JAMA, 284, 1689-1695. M 
 
Merikangas, K. R., & McClair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics, 13, 
779-789. M 
 
Ridenour, T. A., Cottler, L. B., Compton, W. M., Spitznagel, E. L., & Cunningham-Williams, R. M. (2003). Is 
there a progression from abuse disorders to dependence disorders? Addiction, 98, 635-644. W 
Week 10:   
Substance-Related and Addictive Disorders: Current Research and Treatment 
Drake, R. E., O’Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on 
psychosocial interventions for people with co-occurring severe mental and substance use disorders. 
Journal of Substance Abuse Treatment, 34, 123-138. W 
 
McGovern, M. P., Xie, H., Segal, S. R., Siembab, L., & Drake, R. E. (2006). Addiction treatment services 
and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of 
Substance Abuse Treatment, 31, 267-275. M 
 
Miller, W. R., Yahne, C. E., & Tonigan, J. S. (2003). Motivational interviewing in drug abuse services: A 
randomized trial. Journal of Consulting and Clinical Psychology, 71, 754-763. W 
 
Vitkus, J. (1999). Opioid dependence: Residential treatment.  In Casebook in abnormal psychology, 
fourth edition (pp. 119-138). Boston: McGraw-Hill. M 
 
Xie, H., Drake, R. E., McHugo, G. J., Xie, L., & Mohandas, A. (2010). The 10-year course of remission, 
abstinence, and recovery in dual diagnosis. Journal of Substance Abuse Treatment, 39, 132-140. M 
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Week 11:   
Dissociative Disorders and Eating Disorders  
 DSM-5– pp. 291-307; 329-354 
 
 Halgin text: Chapter 7 (Joe) M and Chapter 17 (Sally) W 
 
Guisinger, S. (2003). Adapted to flee famine: Adding an evolutionary perspective on anorexia nervosa. 
Psychological Review, 110, 745-761. W 
 
Spiegel, D., Lewis-Fernandez, R., Lanius, R., Vermetten, E., Simeon, D., & Friedman, M. (2013). Annual 
Review of Clinical Psychology, 9, 299-326. M 
 
Wilson, G. T., & Pike, K. M. (2001). Eating disorders. In D. H. Barlow (Ed.), Clinical handbook of 
psychological disorders, third edition (pp. 332-375).  New York: Guilford. M 
 
Westen, D., & Harnden-Fischer, J. (2001). Personality profiles in eating disorders: Rethinking the 
distinction between Axis I and Axis II. American Journal of Psychiatry, 158, 547-562. W 
 
Wilson, G. T., Grilo, C. M., & Vitousek, K. M. (2007). Psychological treatment of eating disorders. 
American Psychologist, 52, 199-216. W 
Week 12:   
Personality Disorders 
DSM-5– pp. 645-684 
  
Halgin Text: Chapter 3 (Murray) 
 
Krueger, R. F., & Eaton, N. R. (2010). Personality traits and the classification of mental disorders: Toward 
a more complete integration in DSM-5 and an empirical model of psychopathology. Personality 
Disorders: Theory, Research, and Treatment, 1, 97-118.  
 
Samuel, D. B., & Widiger, T. A. (2004). Clinicians’ personality descriptions of prototypic personality 
disorders. Journal of Personality Disorders, 18, 286-308.  
 
Skodol, A. E. (2012). Personality disorders in DSM-5. Annual Review of Clinical Psychology, 8, 317-344.  
Week 13:   
Personality Disorders 
 Halgin Text: Chapter 2 (Ann)  
 
Leichsenring, F., & Leibing, E. (2003). The effectiveness of psychodynamic therapy and cognitive 
behavior therapy in the treatment of personality disorders: A meta-analysis. American Journal of 
Psychiatry, 160, 1223-1232. 
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Linehan, M. M., Cochran, B. N., & Kehrer, C. A. (2001). Dialectical behavior therapy for borderline 
personality disorder.  In D. H. Barlow (Ed.), Clinical handbook of psychological disorders, third edition 
(pp. 470-522). New York: Guilford.  
Week 14:   
Somatic Symptom & Related Disorders, Sexual Disorders, Impulse Control Disorders, Neurocognitive 
Disorders 
 DSM IV – pp. 309-327, 423-459, 685-705, 461-480, 591-643 
 
 Halgin Text: Chapter 9 (Ernie)  
 
Byne, W., Bradley, S. J., Coleman, E., Eyler, A. E., Green, R., Menvielle, E. J., Tompkins, D. A. (2012). 
Report of the American Psychiatric Association task force on treatment of gender identity disorder. 
Archives of Sexual Behavior, 41, 759-796.  
 
Jacobson, A. M. (2001). Medically unexplained symptoms. In Jacobson, J. L., & Jacobson, A. M., 
Psychiatric Secrets, Second Edition, NY: Lippincott.  
 
Stuart, S., Noyes, R., Starcevic, V., & Barsky, A. (2008). An integrative approach to somatoform disorders 
combining interpersonal and cognitive-behavioral therapy and techniques. Journal of Contemporary 
Psychotherapy, 38(1), 45-53.  
Week 15:   
Final Thoughts: Synthesis and Presentations 
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